Digital Mind-Body Therapy for Neoadjuvant Breast Cancer Trial
Summary
The National Institutes of Health has registered ClinicalTrials.gov study NCT07541664, a single-center, randomized controlled, prospective trial investigating Digital Mind-Body Therapy based on digital music and biofeedback during neoadjuvant treatment in patients with locally advanced breast cancer. The study lists neoadjuvant therapy as the condition and DMBT as the intervention. No compliance obligations or regulatory deadlines are associated with this study registration.
What changed
This entry adds a new ClinicalTrials.gov study record (NCT07541664) to the public registry. The trial will investigate Digital Mind-Body Therapy using digital music and biofeedback as an intervention during neoadjuvant treatment for locally advanced breast cancer patients. No regulatory obligations, reporting requirements, or compliance deadlines are created by this registration.
For clinical researchers and healthcare providers: this study registration may be relevant to institutional review boards assessing competing or complementary trial portfolios, and to patients seeking neoadjuvant breast cancer trial enrollment. The single-center, randomized controlled design with approximately 300 participants represents a modest addition to the mind-body intervention evidence base.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Digital Mind-Body Therapy for Neoadjuvant Breast Cancer
N/A NCT07541664 Kind: NA Apr 21, 2026
Abstract
This study is a single-center, randomized controlled, prospective trial investigating the application of Digital Mind-Body Therapy based on digital music and biofeedback (DMBT) during neoadjuvant treatment in patients with locally advanced breast cancer.
Conditions: Neoadjuvant Therapy
Interventions: DMBT
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.